5 cancer organizations join Harvard Business School's Kraft Precision Medicine Accelerator

Boston-based Harvard Business School's Kraft Precision Medicine Accelerator added five cancer organizations that are collaborating to advance precision medicine opportunities across the cancer care arena.

The organizations include:

• LUNGevity Foundation
• Metastatic Breast Cancer Alliance
• Multiple Myeloma Research Foundation
• Pancreatic Cancer Action Network
• Prostate Cancer Foundation

The accelerator is focused on developing a business framework to share solutions that help advance precision medicine. It will work to enhance four elements of precision medicine: direct to patient; data and analytics; clinical trials; and venture and investment.

It is currently testing the "Right Track," a framework that connects cancer patients with patient-focused organizations to enable them to optimize their treatment journey. The framework was developed using market research that pinpointed gaps in knowledge and actions among patients with five types of cancer.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars